Edition:
United States

Tasly Pharmaceutical Group Co Ltd (600535.SS)

600535.SS on Shanghai Stock Exchange

36.81CNY
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
¥36.81
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,672,024
52-wk High
¥44.90
52-wk Low
¥34.70

Latest Key Developments (Source: Significant Developments)

Tasly Pharmaceutical's 9-month net profit up 13.5 pct y/y
Wednesday, 25 Oct 2017 04:40am EDT 

Oct 25 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says 9-month net profit up 13.5 percent y/y.  Full Article

Tasly Pharmaceutical's H1 net profit up 10.4 pct y/y at 756.2 mln yuan
Tuesday, 15 Aug 2017 03:43am EDT 

Aug 15 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says H1 net profit up 10.4 percent y/y at 756.2 million yuan ($113.25 million).  Full Article

Tasly Pharmaceutical Group says JV receives clinical trial approval
Monday, 17 Jul 2017 02:20am EDT 

July 15 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:* Says 50 percent owned JV received clinical trial approval from China Food and Drug Administration regarding injection for hepatitis B treatment.  Full Article

Tasly Pharmaceutical Group to pay FY 2016 annual div on June 15
Friday, 9 Jun 2017 03:03am EDT 

June 9(Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS> ::* Says it will pay FY 2016 dividend to shareholders of record on June 14.* The company's shares will be traded ex-right and ex-dividend on June 15 and the dividend will be paid on June 15.  Full Article

China's Tasly Pharma, France's Pharnext plan JV in China
Tuesday, 9 May 2017 07:36am EDT 

May 9 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says unit plans to invest 20 million euros ($21.79 million) in Pharnext S.A. For 12.6 percent stake.Says it and Pharnext plan to invest 200 million yuan to set up JV in China for technology innovation and product development.  Full Article

Tasly Pharmaceutical's Q1 net profit up 14.8 pct y/y
Friday, 14 Apr 2017 04:27am EDT 

Tasly Pharmaceutical Group Co Ltd <600535.SS> :Says Q1 net profit up 14.8 percent y/y at 318.1 million yuan ($46.19 million).  Full Article

Tasly Pharmaceutical to pay annual cash div as 5.60 yuan per 10 shares for FY 2016
Sunday, 2 Apr 2017 11:47am EDT 

Tasly Pharmaceutical Group Co Ltd <600535.SS> :Says it plans to pay annual cash dividend as 5.60 yuan(pre-tax) per 10 shares as FY 2016 div payment.  Full Article

Tasly Pharmaceutical's 2016 profit down, to issue up to 2 bln yuan commercial paper
Thursday, 30 Mar 2017 08:30am EDT 

Tasly Pharmaceutical Group Co Ltd <600535.SS> : Says 2016 net profit down 20.4 percent y/y .Says it plans to issue up to 2.0 billion yuan ($290.36 million) commercial paper.  Full Article

Tasly Pharmaceutical group's sub-subsidiary to invest in Shanghai bio-tech firm after merged by unit
Friday, 24 Mar 2017 07:36am EDT 

Tasly Pharmaceutical Group Co Ltd <600535.SS> : Says Tianjin-based firm Genexine, in which co's unit owns 33.34 percent stake, signed cooperation framework agreement to merge a Shanghai-based bio-tech firm . Says the Shanghai-based bio-tech firm will be wholly owned by Tianjin-based firm Genexine .Says co's bio-tech sub-subsidiary and CBC Investment I-Mab Limited will boost capital of $38.3 million and $111.8 million to the merged entity respectively.  Full Article

Tasly Pharmaceutical Group says positive result from Topline Analysis Report of compound Danshen dripping pills
Monday, 26 Dec 2016 05:42am EST 

Tasly Pharmaceutical Group <600535.SS>: Says the Topline Analysis Report of its compound Danshen dripping pills proves that its compound Danshen dripping pills have positive treatment effect for angina pectoris .Says the clinic trial is for the New Drug Application of U.S FDA.  Full Article

BRIEF-Tasly Pharmaceutical's unit gets approval to issue up to 1 bln yuan asset-backed securities

* SAYS UNIT GETS APPROVAL TO ISSUE UP TO 1.0 BILLION YUAN ($151.56 million) ASSET-BACKED SECURITIES Source text in Chinese: http://bit.ly/2zBfelT Further company coverage: ($1 = 6.5979 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)